Crossmark

Tau and neurodegenerative disease: the story so far

Crossref DOI link: https://doi.org/10.1038/nrneurol.2015.225

Published Online: 2015-12-04

Published Print: 2016-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iqbal, Khalid

Liu, Fei

Gong, Cheng-Xin
License Information

Text and Data Mining valid from 2015-12-04
More Information

Article History

First Online: 4 December 2015

Competing interests

: K.I. serves on the scientific advisory board of AXON Neuroscience, has received research grants from Ever NeuroPharma and Signum Biosciences, and holds several patents on treatment of Alzheimer disease and related conditions. C.-X.G. serves on the scientific advisory board of Alectos Therapeutics. F.L. declares no competing interests.